It helps regulate blood sugar, slows digestion, increases feelings of fullness, and signals the brain to reduce appetite
GLP-1 stimulates glucose-dependent insulin secretion and suppresses glucagon release, helping lower blood sugar, slows gastric emptying, and promotes satiety
But heres what most people dont realize until its too late: rapid weight loss from these medications doesnt just burn fat
Related Articles: - Retatrutide: Complete Guide - Retatrutide Side Effects - How to Get Retatrutide - Best Peptides for Weight Loss - Getting Started with Peptides Helpful Tools Related Articles Retatrutide Availability & Timeline Retatrutide is expected to receive FDA approval in mid-2027 with pharmacy availability in late 2027
In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks
299 More recent studies have found that GLP-1R agonists can improve lung function in patients/animals with lung pathology and could be a new treatment for patients with lung diseases such as chronic obstructive pulmonary disease and asthma
